Effect of splenectomy on T lymphocyte subsets in patients infected with the human immunodeficiency virus

Area of Science:

• Immunology
• Virology
• Clinical Medicine

Background:

• Assessing immune status in human immunodeficiency virus (HIV)-infected patients is critical for treatment and prognosis.
• Splenectomy can alter immune parameters, potentially affecting the interpretation of standard immune markers.
• CD4 lymphocyte count and CD4 percentage are key indicators of immune function in HIV infection.

Purpose of the Study:

• To determine whether the absolute CD4 lymphocyte count or the CD4 percentage is a more accurate indicator of immune status in splenectomized HIV-infected patients.
• To investigate differences in immune marker interpretation between splenectomized and nonsplenectomized HIV-infected individuals.

Main Methods:

• A case-control study design was employed, matching nine splenectomized HIV-infected cases with controls.
• Controls were matched based on either CD4 lymphocyte count or CD4 percentage.
• Statistical analyses were performed to compare immune parameters and clinical stages between cases and controls.

Main Results:

• When controlling for CD4 count, significant differences in CD4 percentage and trends in CDC clinical stage were observed between splenectomized and nonsplenectomized patients.
• When controlling for CD4 percentage, significant differences in CD4 count were found, but not in CDC clinical stage.
• The relationship between CD4 count and CD4 percentage differs in splenectomized HIV-infected patients compared to nonsplenectomized patients.

Conclusions:

• The CD4 percentage appears to be a more reliable indicator of underlying immune function in splenectomized HIV-infected patients, particularly those with >200 CD4 cells/mm3.
• These findings highlight the need for careful interpretation of immune markers in the context of splenectomy in HIV-infected individuals.